Blackstone to buy drug maker Ayumi in maiden Japan PE deal

Blackstone Group LP headquarters stands in New York, U.S., on Friday, April 14, 2017. Photograph: Victor J. Blue/Bloomberg

Blackstone Group said on Friday it had agreed to buy Japanese drug maker Ayumi Pharmaceutical Corp, a deal one person said was worth around $1 billion.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.